WE SEE

FURTHER

Advancing the vision of ophthalmology

IACTA Pharmaceuticals is an innovative ophthalmic company developing a portfolio of novel assets in large ocular markets, beginning with ocular pain and dry eye disease.

See how

A new era in ophthalmology

Due to an emerging gap between small research firms and large pharmaceutical companies, research ideas with great potential have limited opportunities for development. IACTA is filling this gap to accelerate innovation, address unmet need, and advance the eye care industry.

Learn more

Dedicated and experienced team

IACTA’s leadership brings extensive experience with a history of success in ophthalmology, R&D execution, and pharmaceutical startups. Our team is dedicated to bringing the best ophthalmic innovations to market.

Learn more

Emerging innovative technologies

We identify ground-breaking technologies that will make a difference in patients’ lives and launch them into effective eye care products.

Learn more

See further with IACTA

IACTA Pharmaceuticals is an R&D focused company that is creating innovative treatment-opportunities in the ever-growing industry of ophthalmology and eye care.

Using our wide range of expertise, we are able to identify new technologies and transform them into beneficial treatments that can help many patients worldwide.

With a resolute emphasis on knowledge-based innovation, proven skills of individuals and unique partnerships, I think we are witnessing a new era in ophthalmic products.

STEVE JOHNSON

CHIEF OPERATING OFFICER

Treating therapeutic areas in

OPHTHALMOLOGY

Targeting two therapeutic areas

Dry eye and ocular pain are two large therapeutic areas with significant unmet need

Filling the gap in the pipeline

Major pharmaceutical companies have created a large gap in the market as they significantly reduced their internal R&D efforts

Significant market potential

The global eye care market size is growing due to aging population, increased screen use, and climate change

Learn more about therapeutic areas

Industry experienced

LEADERSHIP

Ophthalmology is a niche therapeutic area that requires specific expertise

IACTA is led by former top executives from the leading eye care companies in the world. With their collective knowledge of global R&D operations, formulation development, and regulatory, they are driving IACTA to success.

DAMON BURROWS

CO-FOUNDER & CHIEF EXECUTIVE OFFICER

WILLIAM PEDRANTI

CO-FOUNDER & CHIEF ADMINISTRATIVE OFFICER

GEORGE NG

CO-FOUNDER & CHIEF BUSINESS OFFICER

OREST OLEJNIK

CHIEF SCIENTIFIC OFFICER

STEVE JOHNSON

CHIEF OPERATING OFFICER

YOGESH BAHL

CHIEF FINANCIAL OFFICER

Eric Carter

ERIC CARTER

CHIEF MEDICAL OFFICER

Learn more about our executive team

Our business partnerships

We’re partnering with the best in the pharmaceutical industry to bring patients effective and innovative eye care products

Meet our leadership team

Cutting-edge and innovative

R&D

Enhanced delivery to ocular tissues

New technologies including nano-encapsulation are providing a breakthrough in the ability to deliver drugs to the eye

Learn more about our R&D

Up-to-date

News

FEATURED STORY

IACTA Pharmaceuticals and Pharmaleads to Develop the World’s First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain

Ocular pain is a $10+ billion global market with significant unmet medical need. IACTA and Pharmaleads are teaming up to accelerate global development of DENKIs, leveraging expertise and resources of both companies.

Read more

MORE NEWS

See more news

Let’s get

Connected

The team at IACTA understands that building a pharmaceutical company is more than science and technology. We need people like you!

We would love to hear from you if you have interest in areas of clinical development to commercial.

Send us a message